On Monday, Recursion Pharmaceuticals Inc (NASDAQ: RXRX) was -3.98%% drop from the session before settling in for the closing price of $5.03. A 52-week range for RXRX has been $3.79 – $12.36.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -35.28% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 15.16%. With a float of $310.78 million, this company’s outstanding shares have now reached $399.15 million.
In terms of profitability, gross margin is -0.08%, operating margin of -960.64%, and the pretax margin is -962.73%.
Recursion Pharmaceuticals Inc (RXRX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Recursion Pharmaceuticals Inc stocks. The insider ownership of Recursion Pharmaceuticals Inc is 23.55%, while institutional ownership is 60.53%. The most recent insider transaction that took place on Mar 27 ’25, was worth 836,987. In this transaction Chief Executive Officer of this company sold 138,574 shares at a rate of $6.04, taking the stock ownership to the 1,117,450 shares. Before that another transaction happened on Mar 27 ’25, when Company’s Officer proposed sale 138,574 for $6.04, making the entire transaction worth $836,987.
Recursion Pharmaceuticals Inc (RXRX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 15.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.10% during the next five years compared to -35.28% drop over the previous five years of trading.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Trading Performance Indicators
You can see what Recursion Pharmaceuticals Inc (RXRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 32.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.15 in one year’s time.
Technical Analysis of Recursion Pharmaceuticals Inc (RXRX)
Let’s dig in a bit further. During the last 5-days, its volume was 27.45 million. That was better than the volume of 24.12 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.07%.
During the past 100 days, Recursion Pharmaceuticals Inc’s (RXRX) raw stochastic average was set at 12.14%, which indicates a significant decrease from 32.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.48% in the past 14 days, which was lower than the 106.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.93, while its 200-day Moving Average is $6.36. However, in the short run, Recursion Pharmaceuticals Inc’s stock first resistance to watch stands at $5.01. Second resistance stands at $5.20. The third major resistance level sits at $5.34. If the price goes on to break the first support level at $4.68, it is likely to go to the next support level at $4.54. The third support level lies at $4.35 if the price breaches the second support level.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Key Stats
There are 406,495K outstanding shares of the company, which has a market capitalization of 1.96 billion. As of now, sales total 58,840 K while income totals -463,660 K. Its latest quarter income was 14,750 K while its last quarter net income were -202,490 K.
